Navigation Links
Catastrophic Elephant Man Drug Trial Victims Injected Recklessly

Experts allege that victims of the terrible 'Elephant Man' clinical trial were given the test drug injections at a 'reckless' rate.//

The drug, a monoclonal antibody was TGN 1412 that is supposed to fight leukaemia, multiple sclerosis and rheumatoid arthritis. Confidential documents have revealed that the victims had been injected 15 times faster than when given to monkeys in animal studies.

Scientists claim that this 'reckless' mistake probably explained the disastrous reaction to the drug that has left volunteers fighting for their lives.

The six young men who has volunteered for the trial were all fit and healthy before signing up for the March trial at Northwick Park Hospital in North-West London. After the injection they suffered a host of side-effects, including pain, vomiting and organ failure.

Bar manager Mohamed 'Nino' Abdelhady, 28, had his head swollen up and was described as 'the Elephant Man' by his partner Myfanwy Marshall.

Trainee plumber Ryan Wilson, 20, suffered heart, liver and kidney failure, pneumonia and blood poisoning and remained n a coma for three weeks.

While in coma, he suffered a frostbite-like reaction and eventually lost parts of his fingers and had his toes amputated.

The trial volunteers are launching a multimillion pound damages claim against Parexel, the private research firm which undertook the trial. The victims are now at a risk of contracting cancer and other chronic and incurable diseases such as multiple sclerosis.

An investigation by the Medicines and Healthcare products Regulatory Agency, concluded that no discrepancies existed in the making and testing of the drug but rather was blamed on unpredictable effects of the drug in the human body.

However documents obtained by the Channel 4 program Dispatches has revealed that the speed at which the drug was given could be to blame.

According to them Mr Wilson was given the drug in just four minutes. The others were injected or infused with the solution over periods ranging from three to six minutes. On the other hand monkeys used in earlier experiments were slowly infused with the drug over an hour.

Professor Terry Hamblin, a Southampton University expert on monoclonal antibodies, said: 'When you give an antibody, the quicker you put it in, the more likely you are to get a reaction.

'I usually give it over about six hours. If you give it in less than an hour you get horrific reactions.

'To quickly infuse it over three to six minutes in six individuals I think is reckless.'

Dr David Glover, former chief medical officer of drug developer Cambridge Antibody Technology, said: 'The drug was given too quickly.'

A spokesman at MHRA, which had signaled the go ahead for the human trial after examining the results of animal experiments, said the men were given doses 500 times lower than those used in animals and that said similar drugs have been given to people in the past at a faster rate without any problems.


NLA
'"/>




Related medicine news :

1. The Chemistry Of Sexual Attraction Between Male And Female Elephants
2. A Royal Flush And A White Elephant
3. Elephantiasis Is Eliminated In Egypt Due To Mass Drug Administration
4. Elephant Man Returns Home
5. New Health care Plans to Leave NHS with White Elephants
6. Doxycycline to treat Elephantiasis
7. Jharkhand Elephant may Have Been Poisoned
8. Reindeers Could Hold the Key to Elephantiasis Cure
9. Results Of Human Trials Of Hungarian Bird-Flu Vaccine Expected Today
10. Vaccine For Dengue Fever On Trial In Asia-Pacific
11. DNA Vaccine Trials Against HIV Virus In Sweden Nurture Hope
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts ... Washington, D.C., for the 49th Congress of the International Society of Paediatric Oncology ... of the Center for Cancer and Blood Disorders at Children’s National, and ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... LAWRENCE, Mass. , Oct. 4, 2017 /PRNewswire/ ... developer of single-use, self-contained, illuminating medical devices, today ... National Health Surveillance Agency (or Agência Nacional ... ®. The first single-use, cordless surgical retractor with ... ONETRAC provides optimal access, illumination and exposure of ...
(Date:10/2/2017)... -- The Rebound mobile app is poised to become a ... of prescription drug addiction. The app empowers users to develop ... down their dosage in a safe, controlled manner while maximizing ... first 100,000 people to sign up will enjoy 3 months ... ...
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
Breaking Medicine Technology: